News and Events

AIBN researchers have topped the nation in the 2018 round of Human Frontier Science Program research funding awards.

UQ Researchers have developed a new nanotechnology to monitor drug resistance and diversity of individual cancer cells circulating in the body.

Researchers have developed a new approach to delivering DNA into cells using spikey silica nanoparticles. These nanoparticles transport the genetic cargo across the cell wall while protecting it from degradation.

Professor Linda Lua, Director of the Protein Expression Facility housed at AIBN, is developing a new vaccine candidate for avian influenza.

Researchers have developed a cost-effective method of converting agricultural waste biomass into commercially valuable chemicals for food production, pharmaceuticals, agriculture and other industries.